Connote Healthcare Private Limited

Nalidixic Acid Oral Suspension BP 300 mg contains Nalidixic Acid, a synthetic quinolone antibiotic that conforms to British Pharmacopoeia (BP) standards, ensuring its quality and efficacy. This medication works by inhibiting bacterial DNA gyrase, an enzyme crucial for bacterial DNA replication and repair. By disrupting this process, Nalidixic Acid prevents the growth and multiplication of susceptible bacteria, effectively clearing the infection. The oral suspension form is particularly suitable for pediatric patients and individuals who may have difficulty swallowing tablets.

Nalidixic Acid is primarily indicated for the treatment of uncomplicated urinary tract infections (UTIs) caused by susceptible gram-negative bacteria, including common culprits like E. coli, Enterobacter, Klebsiella, and Proteus species. It is effective over the entire urinary pH range. The typical dosage for adults and children above 3 months (dosage for children is weight-based) for UTIs usually involves taking 300 mg (equivalent to 5 ml of suspension) four times daily for a prescribed duration, typically 7-14 days. It is generally recommended to take this medication on an empty stomach, at least one hour before meals, for optimal absorption. The suspension should be shaken well before each use, and the dose should be accurately measured using a provided measuring device. It is crucial to complete the entire course of treatment as prescribed by your doctor, even if symptoms improve, to prevent the development of antibiotic resistance and ensure complete eradication of the infection. Nalidixic Acid Oral Suspension BP 300 mg should be stored at room temperature, ideally below 30°C (86°F), protected from direct light and moisture, and should not be frozen. It should be kept in its original, tightly closed container. Many Indian pharmaceutical companies manufacture and export Nalidixic Acid Oral Suspension. Prominent manufacturers include Jagsonpal Pharmaceuticals Ltd. (Diarlop), Ranbaxy Laboratories Ltd. (Gramoneg), Sun Pharmaceutical Industries Ltd. (Nalid), Connote Healthcare, Ciron Group, Glumex Pharmaceutical Formulations, and numerous other WHO-GMP certified facilities. These manufacturers adhere to strict quality control measures and comply with international regulatory standards, which are essential for global export, including product registration, appropriate labeling, and necessary import/export licenses in various countries.

• Uncomplicated Urinary Tract Infections (UTIs): Primary indication for treating bacterial infections of the bladder and urinary tract caused by susceptible gram-negative organisms.
• Prophylaxis of Recurrent UTIs: May be used in some cases to prevent recurring urinary tract infections.

Most side effects are generally mild and temporary, often resolving as your body adjusts to the medicine. However, if any side effects persist or become bothersome, it is important to seek medical advice.

Common side effects of Nalidixic Acid Oral Suspension BP 300 mg include:

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Drowsiness
• Skin rash

Tobramycin Ophthalmic Solution is a sterile eye drop containing Tobramycin, an aminoglycoside antibiotic. It works by inhibiting bacterial protein synthesis, thereby effectively killing a wide range of susceptible Gram-negative bacteria (such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae) and certain Gram-positive bacteria (like Staphylococcus aureus). This action helps to clear up bacterial infections in the eye, alleviating symptoms such as redness, discharge, itching, and discomfort.

This solution is primarily used for the treatment of various external bacterial eye infections, including:

• Bacterial Conjunctivitis (Pink Eye): An infection of the conjunctiva, the membrane lining the inside of the eyelids and covering the white part of the eye.
• Bacterial Blepharitis: Inflammation of the eyelids caused by bacterial infection.
• Bacterial Keratitis: An infection of the cornea, the clear front surface of the eye.
• Other superficial ocular infections caused by susceptible strains of bacteria.

The dosage and duration of treatment will vary depending on the type and severity of the infection and should be strictly followed as prescribed by a healthcare professional. Typically, one or two drops are instilled into the affected eye(s) every 4-6 hours, with more frequent application initially for severe infections. It is crucial to complete the full course of treatment, even if symptoms begin to improve, to ensure complete eradication of the infection and prevent recurrence or development of antibiotic resistance.

Common Side Effects:

• Temporary stinging or burning sensation upon instillation
• Mild eye irritation, itching, or redness
• Eyelid swelling or itching
• Tearing or discharge

Rare or Serious Side Effects (Seek immediate medical attention if experienced):

• Signs of a severe allergic reaction: rash, hives, severe itching, swelling of the face, lips, tongue, or throat, difficulty breathing, or wheezing.
• Worsening eye pain or persistent irritation.
• Development of a new fungal or viral infection (with prolonged use).
• Superinfection (overgrowth of non-susceptible organisms).

Important Precautions:

• Tobramycin Ophthalmic Solution is contraindicated in patients with a history of hypersensitivity to tobramycin or other aminoglycoside antibiotics, or any of its components.
• Avoid touching the dropper tip to any surface (including the eye) to prevent contamination.
• Remove contact lenses before instilling the drops and wait at least 15 minutes before reinserting them.
• This medication will not treat viral or fungal eye infections.
• Consult your doctor if symptoms do not improve within a few days or if they worsen.